Earnings

UiPath Stock Surges on AI Agent Adoption and First GAAP Profit

UiPath shares surged nearly 10% after reporting Q1 revenue of $418M, raising fiscal 2027 guidance, and posting its first GAAP profit. AI agent tools featured in 16 of 20 top deals.

James Calloway · · · 3 min read · 1 views
UiPath Stock Surges on AI Agent Adoption and First GAAP Profit
Mentioned in this article
MSFT $460.59 +2.30% NOW $135.47 +8.93% PATH $11.72 +1.21% QQQ $708.93 -1.51% SPY $739.17 -1.20%

UiPath Inc. (NYSE: PATH) saw its stock climb nearly 10% on Monday, reaching $12.88, as investors cheered a strong fiscal first-quarter earnings report that featured better-than-expected revenue, an upward revision to full-year guidance, and the company's first-ever GAAP profit. The rally extended gains from last week's earnings release, with shares opening at $12.31 and touching an intraday high of $12.95.

Financial Highlights and Guidance

The automation software company reported Q1 revenue of $418 million, a 17% year-over-year increase, surpassing analyst estimates. Annualized renewal run-rate (ARR), a key metric representing the yearly value of subscriptions and maintenance based on current contracts, rose 12% to $1.901 billion. For fiscal 2027, UiPath now expects revenue between $1.776 billion and $1.781 billion, up from its prior forecast.

CEO Daniel Dines highlighted that the company's agentic products are "moving from pilot to production," a statement that resonated with traders and set a clear benchmark for future quarters. CFO and COO Ashim Gupta emphasized "operational discipline" as the driver behind the first GAAP profit under U.S. accounting standards.

Analyst Reactions: Mixed but Cautiously Optimistic

Wall Street analysts offered a range of perspectives. Needham's Scott Berg maintained a Buy rating and $15 price target, citing "improving demand and execution." He noted that 16 of UiPath's top 20 deals in the quarter included agentic modules, pointing to AI as a catalyst for larger upsell opportunities.

Morgan Stanley's Sanjit Singh was more cautious, lowering his price target to $15 from $17 while keeping an Equal Weight rating. He called the quarter "solid" but flagged modest ARR flow-through, suggesting the outlook remains in "show-me" territory. BofA Securities raised its target to $13 from $12 but reiterated an Underperform rating, arguing that a discount to infrastructure software peers is warranted due to ongoing doubts about UiPath's long-term value proposition in a rapidly evolving AI landscape.

Overall, analyst consensus on PATH remains Neutral, with an average price target of $14.48, according to Benzinga. Recent notes from BMO Capital, DA Davidson, and BofA Securities were published between May 29 and June 1.

Competitive Landscape Heats Up

UiPath faces intensifying competition from tech giants Microsoft and ServiceNow, both of which are expanding into AI-agent governance and enterprise workflow tools. In May, ServiceNow announced an expanded integration with Microsoft Agent 365, aiming to help companies manage AI agents across platforms—directly challenging UiPath for enterprise budget allocations.

Market Context and Risks

The broader software sector also rallied on Monday, with the iShares Expanded Tech-Software Sector ETF (IGV) gaining approximately 5.3%. The Nasdaq-100 (QQQ) rose 0.4%, while the S&P 500 (SPY) was flat.

Despite the positive sentiment, UiPath cautions that ARR is not a predictor of future revenue. The company's filings highlight risks including customer retention, AI adoption rates, growing competition, and reliance on third-party large language models. If net new ARR declines or AI features remain in pilot without driving meaningful spending, some of the post-earnings gains could erode.

For now, traders are betting on improved execution and a supportive software tape. The key question remains whether UiPath can convert AI interest into steady renewal growth—or if the stock's strength will prove fleeting after earnings day.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →